🇺🇸 Antidiabetic in United States
116 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 116
Most-reported reactions
- Nausea — 22 reports (18.97%)
- Dyspnoea — 13 reports (11.21%)
- Vomiting — 13 reports (11.21%)
- Blood Glucose Increased — 11 reports (9.48%)
- Hypoglycaemia — 11 reports (9.48%)
- Death — 10 reports (8.62%)
- Diarrhoea — 10 reports (8.62%)
- Fatigue — 10 reports (8.62%)
- Anaemia — 8 reports (6.9%)
- Cardiac Failure — 8 reports (6.9%)
Other Metabolic approved in United States
Frequently asked questions
Is Antidiabetic approved in United States?
Antidiabetic does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antidiabetic in United States?
Federico II University is the originator. The local marketing authorisation holder may differ — check the official source linked above.